Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
Completed · Phase 3
Conditions studied: Schizophrenia, Schizoaffective Disorder
In brief
The specific aim of this study is to determine whether the new, long-acting, form of risperidone, Risperdal Consta, improves the ability of schizophrenia patients to benefit from skills training. The hypothesis guiding this study is that Risperdal Consta, by improving verbal memory, will improve the ability to benefit from skills training interventions among schizophrenia patients. The primary objective of this study is to compare patients on Risperdal Consta to patients on other atypical antipsychotic medications in terms of their ability to benefit from skills training interventions. A secondary objective of this study is to determine whether patients taking Risperdal Consta improve in other areas of cognitive functioning and social functioning.
Key facts
- Study ID
- NCT00148083
- Run by
- University of Illinois at Chicago
- People needed
- 5
- Starts
- 2005-09-01
- Expected to finish
- 2006-03-01
- Last updated by the study team
- 2019-05-15
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Schizophrenia or schizoaffective disorder
- Ages 18-55
- Ability to give informed consent
- Good general physical health or stable chronic medical conditions
- Ability to be on a single antipsychotic medication
- History of inattentiveness in psychosocial treatment settings
- Poor social skills
- Must be receiving a single antipsychotic medication
- Must be clinically stable - defined by the absence of prominent delusions, hallucinations, disorganized speech, or grossly disorganized or catatonic behavior. However, there must also be continuing evidence of impairment, as indicated by the presence of negative symptoms or two or more symptoms of schizophrenia listed in Criterion A of the DSM-IV, in attenuated form (e.g., odd beliefs, unusual perceptual experiences).
You may not qualify if…
- Inability to give informed consent
- Substance dependency in the past 6 months
- Diagnosis of dementia
- Significant head injury or other brain injury leading to cognitive impairment
- Mental retardation (premorbid IQ < 65)
- Pregnant or nursing
- Allergy or other significant adverse reaction to risperidone
- Contraindication to Risperdal Consta as only antipsychotic
- Currently taking risperidone
Where it is running
- University of Illinois at Chicago — Chicago, Illinois, United States
- New York Presbyterian Hospital — White Plains, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.